| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/28/2011 | WO2011049059A1 Composition comprising rna-enclosing carrier |
| 04/28/2011 | WO2011049058A1 Water-based paste containing diclofenac sodium |
| 04/28/2011 | WO2011049042A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient |
| 04/28/2011 | WO2011049038A1 Transdermally absorbable donepezil-containing preparation |
| 04/28/2011 | WO2011049036A1 Low-molecular drug-containing nanoparticle |
| 04/28/2011 | WO2011048613A2 Emergency contraceptive |
| 04/28/2011 | WO2011048564A2 Orally disintegrating tablets of flurbiprofen |
| 04/28/2011 | WO2011048563A2 Orally disintegrating tablets of betahistine |
| 04/28/2011 | WO2011048557A1 Orally disintegrating tablets of memantine |
| 04/28/2011 | WO2011048553A2 Pharmaceutical compositions of pde-5 inhibitors and dapoxetine |
| 04/28/2011 | WO2011048496A1 Triptans for the treatment of psoriasis |
| 04/28/2011 | WO2011048494A2 Novel gastroretentive dosage forms of poorly soluble drugs |
| 04/28/2011 | WO2011048493A1 Coated capsules and tablets of a fatty acid oil mixture |
| 04/28/2011 | WO2011048491A2 Amorphous rotigotine co-precipitates |
| 04/28/2011 | WO2011048412A1 Process for improving crystallinity |
| 04/28/2011 | WO2011048388A2 Oral pharmaceutical and nutraceutical compositions |
| 04/28/2011 | WO2011048379A2 Composition |
| 04/28/2011 | WO2011048144A1 Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels |
| 04/28/2011 | WO2011048040A1 Method and formulation for the control of parasites |
| 04/28/2011 | WO2011047870A1 Nested cell encapsulation |
| 04/28/2011 | WO2011047837A2 Melt-granulated cinacalcet |
| 04/28/2011 | WO2011047700A1 Pharmaceutical compositions of sevelamer |
| 04/28/2011 | WO2011047689A2 Liposomes with improved storage stability |
| 04/28/2011 | WO2011047639A1 Pharmaceutical solution of taxanes comprising chelating agent and preparation method thereof |
| 04/28/2011 | WO2011047637A1 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof |
| 04/28/2011 | WO2011047636A1 Pharmaceutical solution of taxanes comprising solubilizer and preparation method thereof |
| 04/28/2011 | WO2011047596A1 Use of hydroxy benzopyrone compounds for preparing medicine useful for for precaution and treatment of fracture and osteoporosis |
| 04/28/2011 | WO2011047595A1 Use of hydroxy benzopyrone compounds in preparing medicine useful for treating leukemia |
| 04/28/2011 | WO2011047576A1 Use of albiflorin for anti-depression |
| 04/28/2011 | WO2011047529A1 Use of flavonoid glycoside compounds in manufacturing medicaments for treating malaria |
| 04/28/2011 | WO2011047486A1 Biodegradable thermoresponsive hydrogels |
| 04/28/2011 | WO2011027097A3 Method of controlling crystallisation |
| 04/28/2011 | WO2011027060A3 Oxytocin treatment for behavioral characteristics associated with autism and shyness disorder |
| 04/28/2011 | WO2011019326A3 Solubility and stability enchancing pharmaceutical formulation |
| 04/28/2011 | WO2011018532A3 Steroid solvates |
| 04/28/2011 | WO2011002424A3 Solubility and stability enchancing pharmaceutical formulation comprising ezetimibe and simvastatin |
| 04/28/2011 | WO2011002422A3 Solubility enhancing pharmaceutical formulation |
| 04/28/2011 | WO2010141806A3 Compositions and methods for delivery of materials |
| 04/28/2011 | WO2010140869A3 Complex, multilayer using the same, and device coated with the multilayer |
| 04/28/2011 | WO2010138868A3 Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems |
| 04/28/2011 | WO2010138770A3 Methods for administration and formulations for the treatment of regional adipose tissue |
| 04/28/2011 | WO2010135736A3 Application and uses of prg4 and therapeutic modulation thereof |
| 04/28/2011 | WO2010129895A3 Cd133 epitopes |
| 04/28/2011 | WO2010122583A3 Oral pharmaceutical compositions of acid labile substances |
| 04/28/2011 | WO2010119384A3 A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same |
| 04/28/2011 | WO2010117873A3 Progesterone solutions for increased bioavailability |
| 04/28/2011 | WO2010116281A3 Substrates having a cleaning composition for improved glide over skin |
| 04/28/2011 | WO2010089128A3 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 04/28/2011 | WO2009131473A8 Composite carrier for powdery drugs, a method of the carrier manufacturing and a plant for manufacturing the composite carrier particles |
| 04/28/2011 | WO2009037584A3 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 04/28/2011 | US20110098797 Drug eluting composite |
| 04/28/2011 | US20110098464 Cellulose interpolymers and methods of oxidation |
| 04/28/2011 | US20110098314 Statins for the treatment of ocular hypertension and glaucoma |
| 04/28/2011 | US20110098266 Method of administering an injectable antibiotic to an animal |
| 04/28/2011 | US20110097420 Cement products and methods of making and using the same |
| 04/28/2011 | US20110097419 Poly(Propargyl-L-Glutamate) and Derivatives Thereof |
| 04/28/2011 | US20110097418 Compositions and methods for treating influenza |
| 04/28/2011 | US20110097417 Melan-a-carrier conjugates |
| 04/28/2011 | US20110097416 Compositions and Methods for Thermo-Sensitive Nanoparticles and Magnetic Nanoparticles |
| 04/28/2011 | US20110097415 Sustained release of pharmaceutical composition containing a safe botanic drug for the treating and preventing of diabetes |
| 04/28/2011 | US20110097414 Pharmaceutical compositions comprising adsorbate of fenofibrate |
| 04/28/2011 | US20110097413 Solid state forms of deferasirox salts and process for the preparation thereof |
| 04/28/2011 | US20110097412 Methods of treatment of endobronchial infections |
| 04/28/2011 | US20110097411 Carrier pellets, method for production thereof and use thereof |
| 04/28/2011 | US20110097410 Formulations of px compounds |
| 04/28/2011 | US20110097409 Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalation |
| 04/28/2011 | US20110097408 Chitosan-based matrices and uses thereof |
| 04/28/2011 | US20110097407 Butenafine Hydrochloride-Containing Aqueous Patch |
| 04/28/2011 | US20110097406 Methods and compositions for retaining ecm materials in hydrogels |
| 04/28/2011 | US20110097405 Estradiol-containing drug delivery system |
| 04/28/2011 | US20110097404 Tamper-resistant oral opioid agonist formulations |
| 04/28/2011 | US20110097403 Extracellular matrix compositions for the treatment of cancer |
| 04/28/2011 | US20110097402 Non-adhesive elastic gelatin matrices |
| 04/28/2011 | US20110097401 Methods for treating gastrointestinal disorders |
| 04/28/2011 | US20110097400 Magnesium system and use thereof in the cosmetics industry |
| 04/28/2011 | US20110097399 Fast dissolving/disintegrating coating compositions |
| 04/28/2011 | US20110097398 Reduction of cross-linking gelatin in gelatin capsules |
| 04/28/2011 | US20110097397 Break resistant gel capsule |
| 04/28/2011 | US20110097396 Peeling capsule with integrated care effect |
| 04/28/2011 | US20110097395 Oral Pharmaceutical Compositions of Buprenorphine and Method of Use |
| 04/28/2011 | US20110097394 Type a gelatin capsule containing pufa in free acid form |
| 04/28/2011 | US20110097393 Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery |
| 04/28/2011 | US20110097392 Antibody bound synthetic vesicle containing molecules for deliver to central and peripheral nervous system cells |
| 04/28/2011 | US20110097391 Phospholipid Emulsion Containing Dihydroquercetin, and Method of Producing Thereof |
| 04/28/2011 | US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists |
| 04/28/2011 | US20110097389 P53 biomarkers |
| 04/28/2011 | US20110097388 Methods of Expressing Proteins with Disulfide Bridges |
| 04/28/2011 | US20110097387 Particulate drug carriers as desensitizing agents |
| 04/28/2011 | US20110097386 Stabilized glucagon solutions |
| 04/28/2011 | US20110097385 Delivery System for Drug and Cell Therapy |
| 04/28/2011 | US20110097384 Transdermal drug delivery device including an occlusive backing |
| 04/28/2011 | US20110097383 Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome |
| 04/28/2011 | US20110097382 Methods and kits for reducing the likelihood of implantation failure and pregnancy-related disorders in recipients of artificial insemination |
| 04/28/2011 | US20110097381 Conformable tissue repair implant capable of injection delivery |
| 04/28/2011 | US20110097379 Directed stem cell recruitment |
| 04/28/2011 | US20110097375 Formulation for preventing or reducing bleeding at a surgical site |
| 04/28/2011 | US20110097374 Methods and Devices for Correcting Spinal Deformity With Pharmaceutical-Eluting Pedicle Screws |
| 04/28/2011 | US20110097372 Devices, methods, and compositions for controlling infections |
| 04/28/2011 | US20110097367 Monolithic in-situ cross-linked alginate implants |
| 04/28/2011 | US20110097364 Macrocyclic lactone compounds and methods for their use |